Company news

Spectral Medical Inc news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Spectral Updates Status Of EUPHRATES Trial

April 14, 2014

Spectral announces fourth quarter and fiscal 2013 results

March 27, 2014

Spectral Diagnostics Provides Clinical Update on the Euphrates Trial

March 11, 2014

Spectral Diagnostics Announces Extension of Warrants

February 24, 2014

Spectral announces status of second interim analysis

January 28, 2014

Spectral Announces Third Quarter 2013 Results

November 13, 2013

Spectral Reaches Enrollment Milestone for its Phase III Euphrates Trial

September 26, 2013

Spectral announces second quarter 2013 results

August 13, 2013

Spectral to present at Wedbush Life Sciences Conference

August 1, 2013

Spectral provides update on its EUPHRATES trial

July 31, 2013

Spectral Diagnostics Announces Board Changes

July 26, 2013

Spectral Diagnostics provides update on results of annual and special meeting

May 23, 2013

Spectral announces first quarter 2013 results

May 15, 2013

Spectral Appoints Vice President of Sales and Marketing

May 7, 2013

Spectral Diagnostics adopts new By-Laws which contain advance notice provisions

April 16, 2013

Spectral Diagnostics Closes $5.6 Million Offering

April 2, 2013

Spectral announces fourth quarter and fiscal 2012 results

March 27, 2013

Spectral Diagnostics increases offering to $5.6 million

March 18, 2013

Toray Industries makes $5 million strategic investment in Spectral Diagnostics

March 7, 2013

Spectral announces results of first interim analysis by Data Safety and Monitoring Board

February 4, 2013

Spectral Announces Enrollment Milestone for its EUPHRATES Trial

December 5, 2012

Spectral announces third quarter 2012 results

November 14, 2012

Spectral announces new clinical data is being presented at international sepsis forum

November 9, 2012

FDA Approves Spectral's Amended Protocol for its Euphrates Trial

September 26, 2012

Spectral to present at Rodman & Renshaw Annual Global Investment Conference on September 10

September 4, 2012

Spectral and Toray expand EAA(tm)/ PMX Theranostic to Saudi Arabia and Turkey

August 16, 2012

Spectral Announces Second Quarter 2012 Results

August 14, 2012

Spectral Diagnostics Provides Update on Euphrates Trial

June 20, 2012

Spectral Diagnostics to Present at Bloom Burton & Co. Healthcare Investor Conference

June 12, 2012

Spectral Diagnostics to present at BioFinance 2012

May 17, 2012

Spectral Announces First Quarter 2012 Results

May 15, 2012

Spectral announces fourth quarter and 2011 results

March 16, 2012

Spectral begins trading on OTCQX

January 11, 2012

Spectral Diagnostics provides corporate update

January 4, 2012

Spectral Diagnostics Inc. announces normal course issuer bid

November 11, 2011

Spectral Announces Third Quarter Results

November 10, 2011

Spectral to Expand its Phase III Sepsis Trial to Canadian Sites

October 25, 2011

Spectral's Endotoxin Activity Assay featured in major publication

September 28, 2011

Spectral to present at Rodman & Renshaw Annual Global Investment Conference on September 13

September 6, 2011

Spectral Shareholders Approve Previously Announced $10 Million Private Placement

August 26, 2011

Spectral Diagnostics Announces Leading Independent Proxy Firms Recommend Spectral Shareholders Vote for the Proposed Private Placement of Spectral Shares to Medwell Capital Corp.

August 16, 2011

Spectral Announces Second Quarter Results

August 11, 2011

Spectral Diagnostics issues corporate update

August 3, 2011

Spectral diagnostics to present at BioFinance 2011

May 19, 2011

Spectral announces first quarter results

May 12, 2011

Spectral achieves important milestone in its pivotal U.S. clinical trial for sepsis

May 5, 2011

Spectral Diagnostics refiles third quarter unaudited interim financial statements

April 11, 2011

Spectral diagnostics announces fourth quarter and 2010 year end results

March 10, 2011

Spectral diagnostics completes conversion of promissory notes

December 31, 2010

Spectral obtains exclusive canadian distribution rights for Toraymyxin?

November 22, 2010

← Newer news releases · Older news releases →

Calls

Decks